Achieve Clinical Research Announces GERD Research Studies in Birmingham, Alabama

FOR IMMEDIATE RELEASE
Vestavia Hills, Alabama, United States of America (Free-Press-Release.com) October 8, 2011 --

Birmingham, Alabama - Achieve Clinical Research, a privately owned research facility, founded in 1998 in Birmingham, Alabama, announces the launch of several research studies to test investigational treatment options for those already diagnosed with Gastroesophageal Reflux Disease (GERD). “Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with GERD," says Hayes Williams, MD, PhD., the Medical Director and Principal Investigator at Achieve Clinical Research since 2001. "Treatments for GERD are one of the research studies we are pleased to continue with at Achieve Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."

The research studies will enroll those already diagnosed with GERD, which includes symptoms like reflux or heartburn. In order to participate in the studies, volunteers must already be diagnosed with GERD.

Achieve Clinical Research will not take volunteers who:

have any evidence or treatment of malignancy within the previous 5 years
have a history of alcohol or substance abuse within the previous 5 years
have used an investigatory medicine or participated in an investigatory study within 30 days of the screening
are pregnant

are breast-feeding



Achieve Clinical Research will provide participants with study related care, including physical examinations, laboratory services and study medications. Participants will also be compensated for time and travel. Achieve is currently enrolling adults aged 18-75 for a GERD study in Birmingham, AL. For more information regarding participation in our research studies, contact Achieve Clinical Research at 205.757.8208, or at www.AchieveClinical.com.

Achieve Clinical Research     alabama     Birmingham     clinical studies     gastroesophageal reflux diseas     gerd